Stay updated on Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial

Sign up to get notified when there's something new on the Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page now lists a newer site revision label 'Revision: v3.5.4', replacing 'Revision: v3.5.3'. This reflects a deployment update to the ClinicalTrials.gov interface rather than a change to the study information.
    Difference
    0.1%
    Check dated 2026-05-15T23:44:15.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Revision: v3.5.3 replaces the previous v3.5.2 on the page. This reflects a minor platform update to the study record interface.
    Difference
    0.1%
    Check dated 2026-04-30T18:07:32.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Added “Type 2 diabetes” related topics, including a MedlinePlus Genetics section.
    Difference
    0.2%
    Check dated 2026-04-23T15:25:00.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T11:18:11.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-18T20:51:46.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Metadata updates include adding the topic 'Type 2 diabetes' and the related topic 'MedlinePlus Genetics', and the site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.2%
    Check dated 2026-03-11T17:28:39.000Z thumbnail image

Stay in the know with updates to Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial page.